Spondyloarthropathies Clinical Trial
Official title:
Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis
The study is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of two dose regimens of Certolizumab Pegol (CZP) in subjects with active axial Spondyloarthritis (axial SpA).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00768950 -
The Characterization of Small Bowel and Colonic Involvement in Patients With Seronegative Spondyloarthritides
|
N/A | |
Recruiting |
NCT03839862 -
Faecal Analyses in Spondyloarthritis Therapy
|
||
Recruiting |
NCT06369324 -
Efficacy of Pain Neuroscience Education and Physiotherapy in Patients Diagnosed With Spondyloarthritis
|
N/A | |
Completed |
NCT03327454 -
Benepali® PEN Patient Satisfaction Survey
|